Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top New York, New York based CEO’ operating in the Health Care space. If you think a CEO’ is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Adam Karp
Co-Founder & CEO of Lively
Prior to Lively, Adam was the Chief Marketing Officer of 1stdibs – the world’s premier destination for unique, luxury design. At 1stdibs, Adam was instrumental in increasing the company’s revenue almost 10x; recruited and led a team of 100 and had full P&L responsibility for 1stdibs’ B2B business. Before 1stdibs Adam worked in senior roles at leading brands such as FreshDirect, Barnes & Noble and Century 21 real estate. At Century 21 he was responsible for developing and launching Century 21’s first website which at the time became the most recognized real estate website in the country and currently generates almost 50 million visits a year. After Century 21, Adam spent almost a decade at Barnes & Noble in increasingly senior roles ultimately becoming VP of Direct Marketing for both the retail stores and online. At Barnes & Noble, Adam managed some of the largest digital marketing programs in the industry, overseeing a budget of $100M. Adam graduated from the The Wharton School at the University of Pennsylvania with a degree in Economics.
Follow Adam Karp:
About Lively: Lively’s mission is to democratize, simplify and de-stigmatize the adoption and use of technically advanced hearing aids.
_______
Laurence Girard
CEO & Founder of Fruit Street
Laurence Girard is the CEO and Founder of Fruit Street which is the first company to deliver the CDCs National Diabetes Prevention Program via telehealth and live video conferencing with registered dietitians. The company had raised more than $20 million in funding from approximately 300 physician investors. Laurence graduated from the Harvard Extension School with a Bachelor’s Degree. His passion for entrepreneurship started during his first year of college when the Harvard Innovation Lab was opened in the Harvard Business School campus. While in college, Laurence was volunteering in an emergency room while taking a nutrition epidemiology course. It was at this point he decided our healthcare system needed to focus more on prevention and that he decided to focus his career in public health, technology, and entrepreneurship. Laurence is also the Managing Director of Hippocrates Ventures, a physician funded VC fund. His company Fruit Street recently launched COVIDMD.com, a new national telemedicine service battling the COVID-19 pandemic.
Follow Laurence Girard:
About Fruit Street, Hippocrates Ventures, New Amsterdam Football Club: Fruit Street is a developer of a digital diabetes prevention and weight loss program.
Saeju Jeong
CEO & Co-Founder of Noom
A serial entrepreneur from a young age, Saeju has always an intense desire to help people. He sits on South Korea’s Ministry of Science & Technology’s steering committee and the board of Chonnam Hospital, South Korea’s largest private hospital.
Follow Saeju Jeong:
About Noom: Noom is a psychology-based digital health platform used to provide intelligent nutrition and exercise coaching.
Zachariah Reitano
Co-Founder and CEO of Ro
Zachariah is the CEO and cofounder of Ro. Founded in 2017, Ro is a healthcare technology company with a mission to provide personalized healthcare to everyone on the planet. Ro has three end-to-end verticals: Roman (men’s health), Rory (women’s health), and Zero (fighting addiction). As CEO and cofounder, Zachariah leads all medical and regulatory operations and oversees all verticals. Zachariah was named Inc. Magazine’s 30 Under 30, Business Insider’s 30 Under 40 in Healthcare, and a finalist in EY’s Entrepreneur of the Year. Ro was named #2 in Wellness in Fast Company’s World’s Most Innovative Companies 2019.
Follow Zachariah Reitano:
About Ro, Roman: Ro is a telehealth startup that operates digital health clinics for men’s and women’s health, along with smoking cessation.
Eric Moskow
Chief Executive Officer, Director of Accuity Delivery Systems
Founder, CEO and Executive of several highly successful healthcare ventures; including DDDS, OBDS, and Cybear. Dr. Moskow is recognized as an innovative leader in the efficient operation of medical practices. He formed Outcome Based Delivery Systems, with operations in South Florida, Orlando, Florida and Las Vegas, Nevada, which OBDS sold in October 2011. From its founding in 2006 through the sale of its operations, OBDS built its revenue base from a run rate of $0 in 2006 to more than $80M in 2011. He formed Coral Gate Medical Group, a medical practice in Broward County, Florida, in January 2002 and has operated as its Managing Partner since inception. From 2002 to 2005, Coral Gate’s revenues increased from $350,000 to $3.5 million. From February 2000 through January 2002, Dr. Moskow served as Executive Vice President of Cybear, an information technology company serving the health care industry formed by Andrx Corp. He served as a Director of Cybear from June 1999 to 2002. From September 1996 to January 2000, Dr. Moskow was Executive Vice President of Strategic Planning for Phymatrix, a publicly-traded multi-specialty medical provider network. In addition, during this period and then through March 2002, he served as a Director of Phymatrix and its successor, Innovative Clinical Solutions, Ltd. (“ICSL”). From 1989 to 1997, Dr. Moskow served as an Internist and President of Family Medical Associates in Ridgefield, Connecticut. During part of this same period, from October 1995 to October 1996, Dr. Moskow served as Executive Vice President of Physician’s Choice Management, LLC (“PCM”), which he co-founded. In addition, from 1988 to 1992, Dr. Moskow served as Associate Medical Director in Connecticut for U.S. Healthcare. Dr. Moskow is board certified in internal medicine. He received his B.S. degree from Vassar College in 1980 and his M.D. degree from New York Medical College in 1984.
Follow Eric Moskow:
About Accuity Delivery Systems: Accuity Delivery Systems is a provider of clinical documentation services for the healthcare industry.
Eric Marcotulli
Chief Executive Officer of Elysium
Follow Eric Marcotulli:
About Elysium: Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs.
Andrew Adams
CEO of Headway
Follow Andrew Adams:
About Headway: Headway is a mental healthcare system provider that helps patients connect with therapists and submit insurance claims online.
Sylvana Quader Sinha
Founder, Managing Director and CEO of Praava Health
Sylvana Q. Sinha is founder and CEO of Praava Health, a leading healthcare company focused on improving health outcomes and patient journeys in emerging markets, where 85% of the world lives but whose current systems typically prioritize profits over patients.
Since launching in 2018, Praava has become Bangladesh’s fastest-growing consumer healthcare brand, and was designated a 2021 World Economic Forum Technology Pioneer and 2020 Fast Company World Changing Idea and Developing World Technology. Praava has served more than 300,000 patients and is tripling growth each year. Throughout the COVID-19 pandemic, Praava quadrupled its patient base while maintaining an NPS rating of 91.3—significantly exceeding even the highest scores of Fortune 500 companies.
Sylvana also has decades of experience leading teams in international law, business, development, and government relations at major international law firms, management consulting firms, the World Bank, and think tanks in the Middle East and S. Asia. In addition to serving as an advisor to then-Senator Obama, she has independently advised private and sovereign clients on investments, projects, and disputes in the Middle East, Africa, and S. Asia.
Sylvana is a Life Member of the Council on Foreign Relations, a member of the World Economic Forum’s UHC2030 Private Sector Constituency, and served on Mount Sinai’s Arnold Institute of Global Health Task Force for Global Advantage. She is a graduate of Columbia Law School, Harvard’s Kennedy School, and Wellesley College and was a Visiting Scholar at the University of Oxford.
Follow Sylvana Quader Sinha:
About Praava Health: Praava Health is a patient-driven company disrupting the healthcare standard for Bangladesh’s 170 million citizens.
Christopher Morris
Founder & CEO of Daybreak Health
Christopher is an Internal Medicine and HIV specialist at NYU Langone Medical Center focused on digital health innovations as means to transform health care quality and access. He is most interested in using emerging telehealth technologies to transform the primary care experience.
Follow Christopher Morris:
About Daybreak Health, NYU Langone Health, NYU Langone Medical Center: Daybreak Health is a digital health platform that facilitates mobile care solutions.
Bridget Osetinsky
Founder & CEO of Hyperfine
Bridget is the Founder and Chief Executive Officer of Hyperfine. She earned her Juris Doctor from Temple University James E. Beasley School of Law in 2011 and her Bachelor of Science in Physics from the University of Notre Dame in 2007.
Follow Bridget Osetinsky:
About Hyperfine: Advanced Analytics For Precision Medicine
Mario Schlosser
CEO of Oscar Health
Mario Schlosser is the CEO and co-founder of Oscar, a health-insurance start-up that is using technology, design, and data to help humanize and simplify healthcare. Previously, he co-founded the largest social gaming company in Latin America, where he led the company’s analytics and game design practices. At Bridgewater Associates, Mario developed analytical trading models as a Senior Investment Associate. Prior to Bridgewater, he worked as a consultant for McKinsey & Company in Europe, the U.S. and Brazil. As a visiting scholar at Stanford University, Mario wrote and co-authored 10 computer science publications, including one of the most-cited computer science papers published in the past decade, in which he developed an algorithm to securely compute trust in randomized networks. He holds a degree in computer science with highest distinction from the University of Hannover in Germany and an MBA from Harvard Business School.
Follow Mario Schlosser:
About Bridgewater Associates, Oscar Health: Oscar is a health insurance company that offers individual and family plans, medicare advantages, and small group products.
Agustin Fernandez III
CEO & Co-Founder of Rational Vaccines
Follow Agustin Fernandez III:
About Duende Media, Rational Vaccines: Rational Vaccines is a pre-clinical stage that develops live-attenuated herpes simplex virus vaccines.
Paul Parmar
Founder & Group Chief Executive Officer of Constellation Healthcare Technologies
Parmar has provided consultancy services to a number of the world’s largest companies including a major healthcare company, to improve their operational platforms by reducing costs and driving efficiencies. Parmar has previously invested in healthcare businesses and technologies. In 2008 a group represented by Parmar bought a controlling interest in a medical billing company and subsequently sold the business to NextGen. In 2013 he founded Constellation Health to acquire Orion. Parmar built a private aviation business through both acquisition and organic growth which was sold to Delta Airlines in 2010.
Follow Paul Parmar:
About Constellation Healthcare Technologies, Pegasus Blue Star Fund, Vericlaim: Constellation Healthcare Technologies provides a holistic, integrated suite of practice management support services to hospitals.
Jonathan M. Rothberg
Co-Founder, Product Architect & CEO of Butterfly Network
Jonathan Rothberg is Co-Founder, Product Architect & CEO at Butterfly Network.
Follow Jonathan M. Rothberg:
About Butterfly Network: Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.
Richelieu Dennis
CEO & Founder of Sundial Brands
Sundial Brands founder and CEO Richelieu Dennis has a passion for entrepreneurship and innovation that traces back to his family’s roots in Africa and that is sustained by a vision to fill unmet consumer needs. This passion has resulted in the independent 26-year-old family-owned & operated manufacturing company’s success today as the maker of top hair, natural, bar soap and bath and body brands via its SheaMoisture and Nubian Heritage lines, as well as its newest brands and forays into prestige beauty via its Madam C.J. Walker Beauty Culture hair care line and Nyakio skin care line.
Follow Richelieu Dennis:
About Essence Ventures LLC, New Voices Fund, SheaMoisture, Sundial Brands: An Amityville, N.Y.-based maker of branded skin and hair products
Coley Parry
CEO and Founder of FriendHealth
Coley Parry is the Founder & CEO of FriendHealth.
Follow Coley Parry:
About FriendHealth: FriendHealth is a risk-bearing provider that deploys multidisciplinary care teams and proprietary technology to bring health home.
David Ronick
Co-Founder and CEO of Minded
David is a co-founder of Minded and Stash, an LP in The Fund, and mentor to entrepreneurs at TechStars, Harvard Business School and Brown University
Follow David Ronick:
About Minded: Minded is a consumer telehealth company that makes getting mental health medication easy and affordable
Jason Feldman
Co-Founder & CEO of Vault Health
Co-Founder & CEO at Vault Health.
Follow Jason Feldman:
About Vault Health: Vault Health is a telehealth company that leverages diagnostics, specialty telehealth capabilities, and technology infrastructure.
Clay Larsen
President and CEO, Co-Founder of Vesselon
Mr. Larsen co-founded Vesselon in 2012 and brings over thirty years of executive management, marketing, sales, clinical innovation and engineering/project management in the healthcare industry. Mr. Larsen was a senior executive with FUJIFILM Medical Systems, where he was largely responsible for building the company’s first healthcare software division from the ground up. Mr. Larsen recruited the original senior architects and was instrumental in the development, marketing, commercial release and field support of Fuji’s Synapse® Picture Archive and Communication System (PACS). In a move to Silicon Valley in 1988, Mr. Larsen served in several senior roles at Acuson Corporation culminating as Vice President of New Market Development. Acuson was one of the leading ultrasound technology companies that was later acquired by Siemens. Early in his career he specialized in Sales and Marketing Management of Ultrasound and Nuclear Medicine for Picker International. Mr. Larsen holds a B.S. in Molecular Biophysics and Biochemistry from Yale University.
Follow Clay Larsen:
About Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Patrick Freuler
Founder and CEO of Audicus
Patrick Freuler is the founder of Audicus, an internet platform that aims to make hearing aids more affordable. He previously worked at McKinsey and Bain Capital, before co-founding Imperdivel, a leading social e-commerce platform in Brazil. Patrick holds BSc. and MSc. in engineering from MIT.
Follow Patrick Freuler:
About Audicus: Audicus is an e-commerce startup that offers high-tech, affordable hearing aids online.
Howard Solomon
Chairman & CEO of Forest Laboratories
Mr. Howard Solomon has been the President of Clinical Data Inc. since April 13, 2011. Mr. Solomon has been the Non Executive Chairman and Senior Advisor of the Board of Forest Laboratories Inc. since October 1, 2013. He serves as the Chairman and Chief Executive Officer of Forest Pharmaceuticals, Inc. He began his career as an attorney at leading law firms in New York and joined Forest in 1964 as a director and secretary of the Board while serving as outside counsel for the Company. He served as the Chief Executive Officer of Forest Laboratories Inc. since 1977 until October 1, 2013, and served as its President until October 1, 2013. He serves as also served as the Chairman of Forest Laboratories Inc. He has been a Director of Forest Laboratories Inc. since 1964 and Clinical Data, Inc. since April 13, 2011. Mr. Solomon is a Trustee of the New York Presbyterian Hospital and previously served on the Board of Cold Spring Harbor Laboratories. He is a Member of the Executive Committee of the Board of Directors at the Metropolitan Opera and Chairman of its Finance Committee. He also serves on the Board of the New York City Ballet. Mr. Solomon graduated from the City College of New York and holds a J.D. from Yale University.
Follow Howard Solomon:
About Forest Laboratories: Forest Laboratories, Inc. (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships.
Neel Master
Chief Executive Officer and Co-founder of Cohort
Neel combines experience as a published AI/ML researcher, venture capitalist and serial entrepreneur. He worked previously with Rick Toren to develop population health analytics based on Clinical AI/NLP which were deployed at a number of the largest healthcare systems in the country. Prior to that he was recruited by investors into Petra Systems (AI for smart grid/renewables) to write the Series B business plan, lead fundraising for $40MM round, help build out the team and scale from $0 to $80MM annually. Neel was an investor at TL Ventures, Smart Technology Ventures and ITU Ventures. He started his career as a researcher at MIT’s CSAIL for five years, leading software development for large-scale, automated machine learning and computer vision systems publishing in CVPR, IJCV. Neel spent an internship at Microsoft Research building computer vision algorithms and tools.
Follow Neel Master:
About Cohort: Cohort is a software to transform chronic care management and clinical trials.
Josh Guttman
Co-Founder and CEO of Small Door
Prior to co-founding Small Door, Josh led a successful with diverse experiences that included management roles at a number of significant technology companies and roles in both investment banking and venture capital. From 2013 – 2017, Josh worked as a Partner on the early stage investing team at Softbank Capital, a $500 million venture capital arm of Softbank Corporation. While at Softbank, Josh led early stage investments in software businesses with a focus on healthcare and real estate. Before Softbank, Josh served as Senior Vice President at Outbrain, the leading content marketing platform, where he oversaw growth of the business from 50 to 250 worldwide employees in a three-year timespan. Previously, in 2007, Josh joined the early team at Sphere and helped grow the business to their eventual acquisition by Aol in 2008. Post-acquisition, Josh led the business as CEO for two years, ultimately initiating its divestiture and sale to Outbrain in early 2011. Josh began his career in investment banking at Robertson Stephens & Co in San Francisco where he participated on more than $400 million of private equity and debt financings from 1998 – 2002. Josh earned an AB from Duke University and an MBA from Columbia University. He lives in Brooklyn with his wife, two daughters, and boxer, Morrison.
Follow Josh Guttman:
About Small Door: Small Door provides veterinary services that are elevated, customer-centric, and hospitality-infused.
Jeff Dachis
Founder, Chairman & CEO of One Drop
After Jeff Dachis was diagnosed with type 1 diabetes, he set out to create a data-driven digital platform that would disrupt the reactive healthcare model. In 2015, One Drop was born. The precision health company combines continuous diagnostics, predictive analytics and machine learning in an award-winning digital solution to deliver cost-saving outcomes for people worldwide living with diabetes and other chronic conditions.
Next, One Drop plans to enter the market with a daily disposable, minimally invasive continuous health sensor in development designed to provide greater flexibility and insights for people living with diabetes compared to fingersticks alone. The availability of this proprietary sensor is subject to receipt of clearance or approval from the U.S. FDA. Before One Drop, Dachis co-founded Razorfish (NASDAQ: RAZF) and led its $55MM IPO, then founded the Dachis Group (acquired by Sprinklr).
Dachis has appeared on Crain’s 40 Under 40 list and was named EY Entrepreneur of the Year. An internet pioneer, having helped create the first banner ad and web animation, Dachis now channels his passion for data, technology, and design at One Drop, building data-driven products that empower people to take charge of their health.
Follow Jeff Dachis:
About One Drop: One Drop is a diabetes management platform that helps people navigate diabetes together.
Ashok Subramanian
Founder/CEO of Centivo
Ashok is a successful founder and CEO with significant expertise in HR and healthcare technology businesses. He is co-founder and CEO of Liazon, the nation’s leading private benefits exchange for active employees. In 2013, Liazon was acquired by Towers Watson. Ashok continues to serve as CEO of Liazon, as well as the Head of Willis Towers Watson’s Group Exchange business. Prior to Liazon, he worked as a strategy consultant at McKinsey & Company. Ashok is often sought out for his expert commentary on private and public exchanges, their role in the new healthcare landscape and their effect on businesses. He received his undergraduate degree from Princeton University, a Masters degree from Stanford University, and an MBA from the Stanford Graduate School of Business.
Follow Ashok Subramanian:
About Centivo: Centivo offers a digital health plan aimed at self-funded employers looking to provide employees with quality care they can afford.
Isabelle Kenyon
Founder, CEO of Calibrate
Isabelle is the Founder & CEO of Calibrate. Prior to Calibrate, she led the business operations, growth, and strategic partnerships & communications teams at Capsule, a technology business that has raised $270 million to rebuild the pharmacy from the inside out. Before Capsule, Isabelle worked at beloved consumer brands in London and New York and was selected to the Forbes 30 Under 30 Retail & E-commerce list in 2015. She began her career as an investment banker in Hong Kong and graduated from the University of Pennsylvania.
Follow Isabelle Kenyon:
About Calibrate: Calibrate is a digital metabolic health business that is changing the way the world treats weight.
Maxime Germain
CEO, Founder of Jour
Follow Maxime Germain:
About Jour: Jour is a guided journaling app that helps teens and adults with battling mental illness and commit mindfulness.
Harry Ritter
Founder and CEO of Alma
Harry Ritter is the Founder of Alma Health.
Follow Harry Ritter:
About Alma: Alma is a membership-based network for mental health care providers.
Samir Housri
CEO & Co-Founder of The Mednet
Samir Housri the CEO & Co-founder of theMednet. Under his leadership theMednet has become the largest online physician network in Oncology and one of the fastest growing in medicine. Samir’s career spans nearly 20 years in digital media that spans operations, technology and strategy. Most recently he was part of the investment team at Rho Ventures where he sat on multiple boards and deployed over $50M in capital. Prior to that, he was part of EMI Music’s global business development team where he drove the launch of EMI’s ad-supported video platform. He was also involved in all aspects of digital content licensing and distribution, including contract negotiations, technical implementation and monetization. Prior to EMI, Samir served as a management consultant with Bain & Company where he worked on strategy for technology and media clients. He started his career as a software engineer for Major League Baseball and was a key member of the team that built MLB.com.
Follow Samir Housri:
About The Mednet: The Mednet is a physician-only community for expert answers to real world clinical questions in oncology.
Oliver Kharraz
CEO & Co-Founder of Zocdoc
Oliver Kharraz, MD, is CEO and founder of Zocdoc. Oliver is the most recent doctor in a 300-year family tradition. Over the course of his wide-ranging career, Oliver has accrued comprehensive experience effecting change and building efficiency in large scale healthcare organizations using information technology. Prior to Zocdoc, Oliver was an Associate Principal at the global management consulting firm McKinsey & Company. During his seven-year tenure at McKinsey & Co., Oliver developed and implemented new patient utilization models for the national health services of a number of governments and major hospital chains. In 1994, Oliver built and sold his first business – a forerunner of early internet software. He later became a resident doctor at the clinic of Ludwig Maximilian University in Munich, where he earned an MD and a Doctorate in Neuroscience. Oliver also has a Masters Degree in Philosophy from the Jesuit College of Philosophy in Munich. He is also a member of the Council on Foreign Relations. Born in Germany, Oliver immigrated to the U.S. during his work for McKinsey & Co. He currently resides in Brooklyn, NY, with his wife and their twin daughters.
Follow Oliver Kharraz:
About Creative Destruction Lab (CDL), Zocdoc: Zocdoc is a digital marketplace company that connects healthcare patients and doctors.
Robin Berzin
Founder & CEO of Parsley Health
Robin Berzin, MD is the founder and CEO of Parsley Health, a primary care medicine provider with a data-driven, whole body approach. A summa cum laude graduate of the University of Pennsylvania, she completed medical school at Columbia University’s College of Physicians and Surgeons and trained in internal medicine at Mount Sinai Hospital in New York City. Dr. Berzin also trained with the Institute for Functional Medicine, where she acts as an advisor on digital technology. She speaks regularly for organizations including Stanford Medicine X, Health 2.0, Rock Health, Summit Series, and Further Future about how health care can be reinvented.
Follow Robin Berzin:
About Parsley Health: Parsley Health is redesigning primary care by integrating the latest in medical testing, technology and nutrition research.
Marc Shore
Chief Executive Officer of Multi Packaging Solutions
Marc Shore is the founder and Chief Executive Officer of Multi Packaging Solutions (“MPS”), a leading manufacturer of print-based specialty packaging for the healthcare, consumer and media end markets. Since its inception in 2005, MPS has experienced significant growth and now operates manufacturing facilities in North America, Asia and Europe, with approximately 9,000 employees worldwide. Keys to the company’s success are Mr. Shore’s guiding principles: to provide products and services that surpass customer expectations, to differentiate the company in the marketplace, and to foster opportunities for employees. Mr. Shore’s print and packaging career began at Shorewood Packaging Corporation (“Shorewood”), where he worked for over 28 years. He was named President of Shorewood in 1991 and Chief Executive Officer in 1995. During his tenure, Shorewood’s sales grew from $60 million in the United States to $700 million worldwide. Shorewood was sold to International Paper in 2000, where Mr. Shore continued to work as President of Shorewood and an officer of International Paper until 2004.
Follow Marc Shore:
About Multi Packaging Solutions: Multi Packaging Solutions provides packaging solutions for healthcare markets.
Vlad Coric
Chief Executive Officer of Biohaven Pharmaceutical
Dr. Coric has more than 15 years of drug discovery and clinical development experience at Yale School of Medicine and Bristol-Myers Squibb. Within the pharmaceutical industry, Dr. Coric has expertise working across therapeutic areas including neuroscience, virology, oncology and immuno-oncology. Most recently, Dr. Coric was the immuno-oncology indication lead for neuro-oncology and glioblastoma. He has been involved in multiple drug development programs including marketed drugs such as ABILIFY® (aripiprazole; partial dopamine agonist), OPDIVO® (nivolumab; anti-PD1), YERVOY® (Ipilimumab; anti-CTLA-4), DAKLINZA® (daclatasvir; NS5A inhibitor) and SUNVEPRA® (asunaprevir; NS3 inhibitor). He has conducted numerous clinical trials in various illnesses including obsessive compulsive disorder, generalized anxiety disorder, major depression, schizophrenia, schizoaffective disorder, Alzheimer’s disease, hepatocellular carcinoma, and glioblastoma. Dr. Coric was the first to report the therapeutic effects of the glutamate-modulating agent riluzole in neuropsychiatric disorders (Coric et al., 2003; 2005; Sanacora et al., 2004) and led the first clinical trial employing cerebrospinal fluid biomarkers to identity and enrich for patients with Prodromal Alzheimer’s Disease while at Bristol-Myers Squibb (Coric et al 2015). Additionally, Dr. Coric spearheaded the design of and led the first global registrational trial using checkpoint inhibitors in glioblastoma. Dr. Coric is an Associate Clinical Professor of Psychiatry at the Yale School of Medicine and has over 50 peer-reviewed publications. He previously served as Chief of the Yale Clinical Neuroscience Research Unit, and Director of the Yale Obsessive-Compulsive Disorder Research Clinic. He has served as President of the Connecticut Psychiatric Society (an 800 member district branch of the American Psychiatric Association). Dr. Coric completed residency training at the Yale Psychiatry Residency Training Program, where he also served as the Program-Wide Chief Resident for the Yale Department of Psychiatry, and Chief Resident on the PTSD firm at the West-Haven Connecticut Veterans Administration Hospital. Dr. Coric earned his medical degree at Wake Forest University School of Medicine in North Carolina.
Follow Vlad Coric:
About Biohaven Pharmaceutical: Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.
Joseph Davi
Co-founder/President & CEO of Med-Metrix
Joe has over 20 years of demonstrated success in healthcare executive leadership. Together with other senior management, Joe directs and executes Med-Metrix’s primary corporate initiatives and actively implements our strategic plans. Prior to becoming Med-Metrix’s CEO, Joe most recently served as the President of Cobblestone Capital Associates, a private equity firm he founded. He has been an investor and board member in several acquisitions and portfolio companies. Previously, Joe was the President and co-founder of MD-X Solutions (acquired by MedAssets), a revenue cycle company named by Deloitte among the 100 fastest growing technology companies in North America. He later served as the President of MedAssets’ revenue cycle services division. Joe’s career also includes positions at Lehman Brothers, Bankers’ Trust, and NPPN, a national Preferred Provider Organization (PPO). Joe holds a Bachelor’s degree in History from Princeton University and an M.B.A in Finance and Accounting from the University of Chicago Booth School of Business. Joe is a Fellow of the Healthcare Financial Management Association (FHFMA) and was named a Finalist by Ernst & Young for Entrepreneur of the Year in 2005.
Follow Joseph Davi:
About Med-Metrix: Med-Metrix provides Performance Management and Revenue Cycle solutions to the healthcare industry.
Tomer Ben-Kiki
Co-Founder & Chief Executive Officer of Happify Health
Follow Tomer Ben-Kiki:
About Happify Health: Happify Health is a healthcare platform, combining digital therapeutics and care delivery solutions to improve mental and physical health.
Chaim Indig
Chief Executive Officer of Phreesia
Since co-founding Phreesia in 2005, Chaim Indig has helped to revolutionize the patient check-in experience. Under his leadership, Phreesia has established a broad national footprint, developed strategic partnerships with some of the world’s largest healthcare companies and earned accolades for its role in generating workplace efficiencies and improving clinical care. Phreesia has earned widespread recognition, most recently with the 2011 TripleTree I Award, and it was named Health Management Technology’s Coolest Product of 2010. Prior to founding Phreesia, Chaim led the successful introduction of high-end analytics software company Spotfire into the pharmaceutical marketing space. Chaim was also an integral member of the original team at Olap@Work, the leader in SQL server front-end tools. Chaim has become a trusted industry expert and speaker, and is recognized as a prominent business leader. In 2011, he was a finalist for Ernst & Young’s Entrepreneur of the Year Award, and he was featured in the Stanford Social Innovation Review as an innovator in the healthcare field.
Follow Chaim Indig:
About Phreesia: Phreesia automates the patient check-in process by collecting personal health information on the PhreesiaPad.
Howard Yeh
Co-Founder, CEO & Board Director of HealthCare.com
Howard Yeh Online marketing entrepreneur and investor. President and Founder of HealthCare.com (Healthcare, Inc.). Founder of ContactUs.com, Inc. (2012), former co-founder of BrokersWeb (a 2x Inc 500 performance marketing company). Former venture capitalist at VantagePoint Capital Partners. Former investment banker at Merrill Lynch. Howard blogs at www.howardyeh.com.
Follow Howard Yeh:
About HealthCare.com: HealthCare.com is an insurtech platform that allows users to analyze health insurance options that are available in their area.
Geoffrey Chaiken
Co-founder & CEO of Blink Health
Geoffrey Chaiken is the Co-Founder & Chief Executive Officer of Blink Health. As the first e-commerce company to bring prescriptions online, Blink Health solves the prescription drug pricing problem in the US by offering patients amazingly inexpensive Rx prices. Patients simply pay for their prescriptions online, before picking them up at their preferred pharmacy or having them delivered to their home. Previously, Geoffrey was the founder of Marinus Pharmaceuticals (Nasdaq: MRNS), a specialty pharmaceutical company developing novel treatments for severe epilepsy. Prior to founding Blink Health, Geoffrey was at Brave Warrior Advisors, where he was one of three investors managing $3 billion. At Brave Warrior, Geoffrey led the firm’s successful investment throughout the technology and pharmaceutical supply chains. Geoffrey has a BA in Biology and Philosophy from Yale University and an MBA from Harvard Business School. Geoffrey has been named Fortune’s 40 Under 40 and several other lists of top leaders in healthcare and business.
Follow Geoffrey Chaiken:
About Blink Health: Blink Health is a web-based application that enables users to search for medical prescriptions online and pick them up from any pharmacy.
Marc Atiyeh
CEO of Pawp
Marc is the former CSO of Clarity Money (Acquired by Goldman Sachs) where he focuses on growth efforts from User Acquisition, Operations, Partnerships, and Marketing. Prior to joining Clarity Money, he was the Head of Growth at Paribus. He oversaw the growth of the company from 10,000 users to almost 1,000,000 in 12 months until Paribus got acquired by Capital One. Prior to that, he was a Business Operations and Planning Analyst at Flurry (acquired by Yahoo). Before he became part of the Flurry team, Marc founded Help Me Get In, a college consulting start-up that mentored 50+ high-schoolers to gain admission into top notch US/UK universities. Marc has also been involved in other industries including ad-tech and venture capital. Marc currently advises The Lobby and Cushion.ai. He graduated from Harvard College, where he earned my degree in Electrical and Computer Engineering. Marc also played on the Harvard squash team. He energized the early stage entrepreneurial community at Harvard and collaborated with the Innovation Laboratory (iLab) at Harvard Business School. Marc graduated High School from College Notre-Dame de Jamhour in Beirut, Lebanon. He also received the French Baccalaureate with highest honors. Marc is fluent in English, French, and Arabic, while having conversational skills in Spanish and Italian. Besides squash, Marc enjoys playing tennis and basketball. Moreover, He is an avid fan of Chelsea F.C. and a poker amateur.
Follow Marc Atiyeh:
About Pawp: Pawp is a digital health clinic and telehealth platform for pet owners and their pets that connects them with veterinary professionals.
Omri Yoffe
Co-Founder & CEO of Vi
Omri Yoffe is Founder & CEO at Vi
Follow Omri Yoffe:
About Vi: Vi is the world’s leading Enterprise-AI for digital health.
Siva Namasivayam
Co-Founder, Board Member & Chief Executive Officer of Cohere Health
Prior to co-founding Cohere Health, Siva was a founding partner of SCIO Health Analytics which served over fifty Fortune 500 clients. Siva’s experience also includes serving as SVP, Chief Revenue Officer at MphasiS, SVP, Payer Services at Dell, and Senior Software Engineer at Intel. Siva received his bachelor’s degree from the National Institute of Technology in Tiruchirappalli. He holds a master’s in computer science from the University of Pittsburgh as well as an M.B.A. from the University of Michigan.
Follow Siva Namasivayam:
About Cohere Health: Cohere Health is a SaaS company that focuses on aligning patients, physicians, and health plans to create optimal care journeys.
Mike Simmons
CEO & Founder of andros
Follow Mike Simmons:
About andros: andros is a provider of network management solutions for healthcare organizations.
Vivek Garipalli
CEO of Clover Health
Vivek Garipalli is a leading international business expert with a focus on the healthcare industry. He has spent the majority of his career starting and developing pioneering healthcare businesses that improve the service patients receive. In fact, Vivek founded five healthcare companies before the age of 40. He has used this considerable experience in the field to co-found Clover Health, a disruptive company that aims to transform the healthcare structure for the better. Prior to establishing Clover Health, Vivek co-founded CarePoint Health in 2008, which is a vertically and horizontally integrated healthcare system in New Jersey. He has recently extended this venture with CarePoint Health Plans, a unique model in the health insurance space that concentrates on the Medicare Advantage Market. When Vivek Garipalli founded CarePoint Health and Clover Health, he saw there was a substantial misalignment between healthcare providers and insurance firms. Vivek intended to decrease doctor-insurer friction whilst increasing the visibility into the health of every patient. He realized that this would improve the service patients receive while making it more accessible. Very little had been done for the uninsured and underinsured patient groups, and Vivek wanted to change that trend. On top of Clover Health and CarePoint Health, Vivek Garipalli co-founded a healthcare services revenue cycle business called Ensemble health. He was also one of the founding investors of Flatiron Health, in which he took an active role on the board in guiding its strategy and growth, ending in its sale to Roche in 2018. Vivek also sits on the board for Doctor Evidence and Medically Home, two innovative companies within healthcare technology. Prior to his entrepreneurial work in healthcare, Vivek Garipalli began his career at Credit Suisse First Boston and following this he held a position at J.P.Morgan Partners’ private equity fund. He went on to work at the Blackstone Group, where his focus focused into restructuring and reorganizing in an advisory capacity. Vivek Garipalli started his journey in business at the University of Emory, where he studied business administration with a focus on entrepreneurship. On top of his successful career, Vivek has supported a number of charities, including The Bowery Mission, a charity that tackles homelessness in New York and Newark.
Follow Vivek Garipalli:
About CarePoint Health, Clover Health: Clover is a healthcare technology company helping members live their healthiest lives with its Medicare Advantage plans.
Tom Aulet
Co-Founder & CEO of Ergatta
Tom Aulet is the Co-Founder and Chief Executive Officer of Ergatta.
Follow Tom Aulet:
About Ergatta: Ergatta is an at-home connected fitness startup that offers a rowing machine and proprietary digital content.
Anthony Girand
CEO, Co-Founder of VoyagerMed
Anthony has over 15 years of experience as a Private Wealth advisor on Wall Street. He left Forbes Family Trust in 2014 to start VoyagerMed and has been spearheading the company’s digital operations ever since. Contact Anthony at anthony@voyagermed.com
Follow Anthony Girand:
About VoyagerMed: A medical tourism marketplace faciliating access to life changing medical innovations from trusted doctors around the world.
Alamin Uddin
Co-founder & CEO of NexHealth
Alamin Uddin is a Co-founder & CEO of NexHealth.
Follow Alamin Uddin:
About NexHealth: NexHealth is a real-time patient booking platform for people, their doctors, and healthcare developers.
Edouard Gaussen
Chief Executive Officer and Co-Founder of Mantra Health
Edouard Gaussen is a Co-Founder and CEO at Mantra Health. Edouard has had experience operating and advising startups on growth and user acquisition. He was one of the early employees at Tinder, a social discovery app based in Los Angeles, which disrupted the online dating industry and creates millions of matches every day. His role evolved from handling all on ground growth strategies in the Canadian market to leading the international marketing team across 15 different markets worldwide. As an active member of the Montreal tech community, Edouard serves as a mentor at the Dobson Centre for Entrepreneurship at McGill University. Edouard holds a B.A. in Economics and Finance from McGill University. Born and raised in Switzerland, he is a dual French-Swiss citizen and calls Montreal home.
Follow Edouard Gaussen:
About Mantra Health: Mantra Health is a digital mental healthcare company designed for all university students.
Allon Bloch
Co-Founder and CEO of K Health
Allon Bloch is the CEO and Co-founder of K Health. Previously he served as the CEO of Vroom, the largest online car retailer in the U.S, Co-CEO of Wix, the world’s leading website publishing platform, and CEO of mySupermarket, a digital platform that empowers consumers to find the best prices for their groceries. Allon is also a former venture capitalist, serving as a Venture Partner with Greylock’s Europe/Israel fund and a General Partner at JVP. He holds an M.B.A. from Columbia Business School and is based in New York.
Follow Allon Bloch:
About K Health: K Health is a data-driven digital primary care system that uses AI to deliver personalized primary care.
Franz Hefti
CEO of Prevail Therapeutics
Franz Hefti is the CEO of Prevail Therapeutics and he holds a Ph.D. from the University of Zurich and completed his postdoctoral research at the Massachusetts Institute of Technology.
Follow Franz Hefti:
About Prevail Therapeutics: Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.
AJ Loiacono
CEO of Capital Rx
AJ Loiacono is the CEO of Capital Rx.
Follow AJ Loiacono:
About Capital Rx: Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.
Tricia Han
CEO of DailyBurn
Tricia Han is the CEO of Daily Burn, a leading on-demand fitness brand. Prior to Daily Burn, Han was the chief product officer at IAC’s Dotdash (formerly About.com). Before joining Dotdash, she was the senior vice president of product management at WebMD. Han has also served as GM and vice president at Daily Candy and has worked with a variety of technology startups, including Juno and Vindigo. She is a graduate of Cornell University.
Follow Tricia Han:
About Care.com, DailyBurn: DailyBurn offers a fitness and nutrition tracking app with features such as detailed tracking, online accountability, and motivation.
Karin Hehenberger
Chief Executive Officer of LyfeBulb
Karin Hehenberger is the Chief Executive Officer at Lyfebulb.
Follow Karin Hehenberger:
About 3B Future Health Fund, LyfeBulb: Lyfebulb’s mission is bridging patient communities with industry, and providing a strong voice to individuals living with chronic disease.
Ian Read
CEO of Pfizer
Ian Read is Chairman of the Board and Chief Executive Officer of Pfizer, one of the world’s premier innovative biopharmaceutical companies, which brings therapies to patients that significantly improve their lives. These include medicines and vaccines along with many of the world’s best-known consumer healthcare products. Previously, he served as Senior Vice President, Pfizer, and Group President of the Worldwide Biopharmaceutical Businesses, which he led from 2006 through December 2010. In that role, he oversaw five global business units — Primary Care, Specialty Care, Oncology, Established Products and Emerging Markets. Ian began his career with Pfizer in 1978 as an operational auditor. He worked in Latin America through 1995, holding positions in a number of Pfizer’s largest, fastest-growing operations, including Chief Financial Officer, Pfizer Mexico, and Country Manager, Pfizer Brazil. In 1996, Ian was appointed President of Pfizer’s International Pharmaceuticals Group, with responsibility for Latin America and Canada. He became Executive Vice President, Europe, in 2000, was named a Corporate Vice President in 2001, and assumed responsibility for Canada, in addition to Europe, in 2002. Ian later became accountable for operations in both the Africa/Middle East region and Latin America as well. Ian received his B.Sc. in chemical engineering from London University Imperial College in 1974. He earned his Chartered Accountants certification from the Institute of Chartered Accountants of England and Wales in 1978. Ian serves on the Boards of PhRMA, Kimberly-Clark and the Partnership for New York City.
Follow Ian Read:
About Pfizer, The Carlyle Group: Pfizer provides access to safe and effective and affordable medicines and health care services.
Jeffrey A. Bailey
Chief Executive Officer of BioDelivery Sciences International
Follow Jeffrey A. Bailey:
About BioDelivery Sciences International: BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.
Jeff Krahel
CEO & Co-Founder of Playbook
Founder at Fitner Media.
Follow Jeff Krahel:
About Playbook: Playbook is the #1 creator economy platform for talent in the fitness & athletic industry.
Lindsay Jurist-Rosner
Co-founder and CEO of Wellthy
Lindsay Jurist-Rosner is the Co-founder at Wellthy.
Follow Lindsay Jurist-Rosner:
About Wellthy: Wellthy is a family care concierge service that brings relief to families managing complex or ongoing care situations.
Andrew Vagenas
CEO of Pharmapacks
Andrew Vagenas is a co-founder and CEO at Pharmapacks.
Follow Andrew Vagenas:
About Pharmapacks: Pharmapacks is an e-commerce company that offers products for daily health and wellness needs.
Aaron Albert
Co-Founder/CEO of Mine’d
Co-Founder/CEO at Mine’d
Follow Aaron Albert:
About Mine’d: The Emotional Network – Daily, live guided emotional health sessions
Craig Elbert
Co-Founder and CEO of Care/of
Craig Elbert is the co-founder and CEO of Care/of. Prior to co-founding Care/of, Craig served as the founder of Juxtapose and vice president of marketing at Bonobos.
Follow Craig Elbert:
About Care/of: Care/of is a healthcare technology company dedicated to simplifying consumer health, starting with a fully personalized vitamin pack.
Ryan Hungate
CEO & Founder of Simplifeye
CEO & Founder of Simplifeye.
Follow Ryan Hungate:
About Simplifeye: Simplifeye empowers doctors by automating the business of their practice
Jordan Feldman
Co-Founder & CEO of Rightway
Bachelor of Arts, Government & Economics – Harvard,Investment Banking – Goldman Sachs,Investment Professional – Redbird Capital.
Follow Jordan Feldman:
About Rightway: Rightway is a health technology company that is simplifying the healthcare experience for clients and members.
Clay Williams
Founder & CEO of Medaptive Health
Entrepreneur, computer scientist, healthcare wonk, cyclist, dachshund lover.
Follow Clay Williams:
About Medaptive Health: Medaptive Health™ is an open source solution for creating health offerings using CareKit, ResearchKit, ResearchStack, and the web.
Iyah Romm
Founder and CEO of Cityblock Health
Iyah Romm is a Founder and CEO at Cityblock Health.
Follow Iyah Romm:
About Cityblock Health: Cityblock Health is a tech-driven healthcare provider for those in underserved communities.
Chocko Valliappa
Chief Executive Officer & Managing Director of Vee Technologies
Chocko Valliappa comes from a family of entrepreneurs, pioneering India’s growth in textiles, agriculture, plantations and more. Recognizing the importance of new technology, he founded the Valliappa Software Tech Park launching Oracle, CISCO and VeriFone in 1995.
Follow Chocko Valliappa:
About HireMee, SonaYukti, Vee Create, Vee FnA, Vee Protect, Vee Technologies, Vee Track: Vee Technologies is a transaction services company delivering total back-office processing solutions.
Samer Hamadeh
Founder & CEO of Zeel
Samer is an entrepreneur-in-residence at Lightspeed Venture Partners, which he joined in January 2010. Samer is currently founder & CEO of Zeel.com. Relaunched in December 2012, Zeel gives consumers the power to book same-day, in-home massage appointments via app or website in under a minute. Prior to that, Samer Hamadeh was co-founder and CEO of Vault.com, the most trusted name in career information, which was sold in October 2007 to Veronis Suhler Stevenson, a New York-based media-and-communications private-equity firm. Before co-founding Vault, Samer was an associate at the Los Angeles management consulting firm LEK Consulting, where he focused on corporate and business strategy. Prior to that, Samer co-founded and managed a customized-textbook printing company, worked at the Chevron Corporation, and co-authored The Internship Bible and America’s Top Internships (Random House/Princeton Review). Samer sits on the board of the non-profit PeaceWorks Foundation and is a board observer, angel investor, and/or advisor in two dozen early-stage companies, including GrubHub, SalesCrunch, Insidr.com, Splurgy, and PublicStuff. Samer is also a mentor at several accelerators, including Blueprint Health, NYCSeedStart, and First Growth Venture Network, as well as a member of Young Presidents Organization (YPO) and the Georgetown McDonough School’s Entrepreneurship Advisory Board. A David Rockefeller Fellow, Samer holds a BS in chemistry and an MS in chemical engineering from Stanford University.
Follow Samer Hamadeh:
About Lightspeed Venture Partners, One Voice Movement, Venture for America, Zeel: Zeel delivers on-demand massage from vetted therapists.
AF_initDataCallback({key: \’ds:1\'” alt=”” class=”wp-image-14850″ width=”154″ height=”152″/>Keith Cowing
Chief Executive Officer of Ruby
Follow Keith Cowing:
About NextGen Venture Partners, Ruby: Ruby specializes in the health and wellness of seniors and their families with home maintenance and healthcare services for a living.
Jeffrey Wessler
Founder, CEO of Heartbeat Health
Follow Jeffrey Wessler:
About Heartbeat Health: Heartbeat Health is a healthcare technology company that delivers virtual-first cardiovascular disease prevention and management.
Humberto Antunes
President & CEO of Galderma
Humberto C. Antunes is a Partner at Gore Range Capital. Humberto has spent his career as an entrepreneur in healthcare and wellness focused on finding ways to improve the lives of people all over the world. His previous experience includes work in dermatology, ophthalmology, medical aesthetics, immunology, inflammation, cosmetics, medical devices, pharma and nutraceuticals. He is actively involved in research to address the issues arising from aging demographics, providing holistic health solutions, helping technologies converge and the digital revolution. Prior to joining Gore Range Capital, Humberto managed Galderma, a pharmaceutical company, for almost 20 years. From 2014 through 2016, he created and led Nestlé Skin Health, which endeavors to enhance quality of life by delivering science-based solutions for skin. Humberto promoted geographic expansion of the businesses he managed, created new channels and acquired new audiences. He also led many successful acquisitions, integrations, joint-ventures, license deals and divestitures. In addition, Humberto has led research teams that achieved hundreds of New Drug Applications, patent filings and clinical trials on both sides of the Atlantic. Some of his successful digital initiatives include www.derm101.com and www.acne.com.
Follow Humberto Antunes:
About Galderma, Gore Range Capital: Galderma offering a range of medical and consumer skin health solutions through three business units.
Jacqueline Novogratz
Founder & CEO of Acumen
Follow Jacqueline Novogratz:
About Acumen: Acumen is a non-profit venture fund that uses entrepreneurial approaches to solve the problems of global poverty.
Ato Kasymov
CEO, Co-Founder of Zentist
Entrepreneur
Follow Ato Kasymov:
About Zentist: Zentist is a dental insurance billing platform that delivers improved practice financial performance and patient affordability.
Brian Bushell
Co-Founder & CEO of By Humankind
Follow Brian Bushell:
About By Humankind: By Humankind is a personal care designed to reduce single-use plastic waste in their daily routine.
Steven Forti
Founder & CEO of FitFight
Prior to FitFight, Steven was a consultant for Johnson & Johnson’s Orthopedic Trauma Division, where he utilized eight years of Critical Care and Trauma Nursing experience. In the military, he earned the rank of Master Sergeant after serving 23+ years in Army Special Forces, where his specialties included Special Forces Weapons Sergeant and Special Forces Intel Sergeant. He is a Level 1 Sniper, and attended Johns Hopkins Applied Physics Lab at DIA as well as the Special Operations Planners Course in Norfolk VA. Steve earned a BS in Nursing from Quinnipiac University, completed a Critical Care Residency at Yale New Haven Hospital Systems, and holds a BS from Southern Connecticut State University.
Follow Steven Forti:
About FitFight: FitFight is a combat veteran owned and operated mobile platform.
Giuliano Senese
Founder & CEO of DX Medical Solutions
Follow Giuliano Senese:
About DX Medical Solutions: Medical Technology Startup
Stuart Hinchen
Co-Founder & CEO of QuVa Pharma
Stuart Hinchen is Founder &CEO @ QuVa Pharma. Stuart Hinchen is currently Chief Executive Officer of JHP Pharmaceuticals, LLC (“JHP”), having acted as President and Chief Operating Officer of JHP from 2007 to 2011. He has been instrumental in the establishment of JHP as a leading injectable pharmaceutical business in the USA. Previously, Stuart was President of Mayne Pharma Americas (“Americas”), a unit of Mayne with $180 million in revenue that was focused on the manufacture, development and sale of generic injectable pharmaceuticals, primarily into the hospital market. Stuart led the Americas activity through a period of significant growth through acquisition, product line extension, and product in-licensing. Having first established Mayne Pharma USA as a stand-alone business, he helped build the division into the fourth largest US generic oncology provider. Prior to his experience with Mayne Americas, Stuart was a General Manager in Mayne’s Mergers and Acquisitions Group, heading transactional and operational teams involved in the purchase, sale and integration of businesses. After joining Mayne in 1995, Stuart worked on a variety of different projects, including the restructuring and sale of the company’s Benelux logistics business to Hays PLC.
Follow Stuart Hinchen:
About QuVa Pharma: QuVa Pharma is a pharmaceutical company engaged in the innovation and production of pharmaceutical products.
Jennifer Blumenthal
CEO and Co-Founder of OneRecord
Follow Jennifer Blumenthal:
About CommonWell Health Alliance, OneRecord, The Sequoia Project: Your Health, Your Life, Your OneRecord.
Alex Dresner
Co-Founder & Co-CEO of Imagen Technologies
Alex is a Co-Founder and the Co-CEO of Imagen. Prior to co-founding Imagen, Alex worked as the Head of the Hospital for Special Surgery’s Value Analytics and Management Office. Alex began his career at Bridgewater Associates where he was a member of the Core Management Team. Alex received his bachelor’s degree from the London School of Economics.
Follow Alex Dresner:
About Imagen Technologies: Powering the future of primary care
Troy Bannister
Founder and CEO of Particle Health
10+ years in healthcare as an EMT, clinical researcher and innovations specialist. Focused on disruptive models and new digital technologies. Founded a company focused on breaking down barriers that make it difficult to share data between large healthcare organizations.
Follow Troy Bannister:
About Particle Health: Particle Health is an API designed for healthcare innovators that gives access to vital medical data.
Michael Satow
CEO of Nutrition 21
Michael has founded several successful ventures. Currently, co-founder and CEO of JDS Therapeutics and Nutrition 21. Also was cofounder and President of JDS Pharmaceuticals, LLC – exited in 2007 for $125 million cash sale http://bit.ly/jPBDk6 2000-2002 CEO Mirror Worlds Technologies, Inc., makers of Scopeware. Cofounder/CEO of MarketXT, Inc – exited in 2000 with $100 million sale http://bit.ly/kBtl7S Lawyer in private practice/SEC enforcement for 4½ years. Currently serve on boards of http://houseparty.com, the Jed Foundation, My Sister’s Place. B.A. from Columbia College and a J.D. from the Georgetown University Law Center.
Follow Michael Satow:
About JDS Therapeutics LLC, Nutrition 21, Skymarker: Nutrition 21 is a supplier of dietary supplements for the health and fitness industry.
Eric Schweiger
CEO & Founder of Schweiger Dermatology
Eric Schweiger, M.D. is the founding dermatologist and C.E.O. of Schweiger Dermatology Group.
Follow Eric Schweiger:
About American Academy of Dermatology, Clear Clinic, Mount Sinai Health System, Schweiger Dermatology: Schweiger Dermatology is a full service cosmetic & general dermatology.
Robb Knie
CEO, President & Director of Hoth Therapeutics
Mr. Knie has served as President and Chief Executive Officer and as a director of the Company since May 2017. Mr. Knie served as the President of Lifeline Industries Inc. since its inception in 1995. From 2002 to 2010 he was a Semiconductor Analyst for PAW Partners. From 1993 until 1995, Mr. Knie served as Northeast Regional Manager of American Express Financial Advisors. Mr. Knie has served as a board member for NASDAQ-listed companies. He has been featured on CNBC, Bloomberg, The Wall Street Journal and Forbes Magazine as an Independent Equity Analyst. Mr. Knie has over 20 years of equity markets experience. Mr. Knie has been a member of the American Chemical Society, Institute of Electrical and Electronics Engineers, as well as The National Alliance for Youth Sports.
Follow Robb Knie:
About Hoth Therapeutics: Hoth Therapeutics is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders.
Elad Walach
CEO and Co-Founder of Aidoc
Elad Walach is a co-founder and CEO of Aidoc. He is an expert in AI with visionary business insights in the healthcare space. Since establishing Aidoc in early 2016, Elad has led the company through 2 rounds of investment (total of $13Mil), driven the commercial availability of 2 product lines (detecting brain hemorrhages and C-Spine fractures), and created an install base of 16 global health systems while growing the company to over 50 employees. Elad began his career in the elite Israeli Defense Force technology program “Talpiot”. He led AI research in the Israeli Air Force where he initiated and managed several teams focused on machine learning and computer vision projects. Elad holds a B.Sc. in Mathematics and Physics from The Hebrew University of Jerusalem, and has published multiple academic papers on deep learning.
Follow Elad Walach:
About Aidoc: Aidoc specializes in developing artificial intelligence tools for radiologists and multidisciplinary response teams.
Chris Mirabile
CEO of NOVOS
Chris Mirabile is Founder & CEO of Healthy Hand, and formerly a co-founder and CEO of the geosocial networking technology, Hotlist. Mirabile, a graduate of New York University Stern School of Business, was the youngest entrant to win the NYU Stern Business Plan Competition, from which Hotlist.com was launched. Mirabile and co-founder Gianni Martire went on to raise an $800,000 first round of capital for their venture from Joseph J. Grano, Jr.’s Centurion Holdings, and was accepted into Mayor Michael Bloomberg’s startup incubator program in the SoHo district of New York City. After more than 700,000 nominations for 25 categories, Chris was a top five finalist in the category of Entrepreneur of The Year at the 2011 Consumer Electronics Show, as part of the 2010 Mashable Awards. Mirabile’s technology career began at age 15, when he worked as a Web Consultant to the now defunct Silicon Alley startup, InternetCash.com. In 2002, at the age of 18, Mirabile led international expansion efforts for a US-based industrial contracting firm, United States Rebar. The resulting Mumbai, India-based technology subsidiary was recently acquired by an international steel conglomerate. Immediately prior to Hotlist, Mirabile worked in Private Equity at Putnam Lovell Investment Bank, and as a Consultant to hedge funds both on behalf of Morgan Stanley, as well as independently.
Follow Chris Mirabile:
About NOVOS: NOVOS is a Longevity supplements brand.
Konstantin Mehl
CEO, Founder & President of Kaia Health
Konstantin is a serial entrepreneur. His last company foodora, a global food delivery company was sold to delivery hero in 2015 after reaching 500 employees and 5,000 drivers. His current company Kaia has the mission to build the biggest platform for chronic disease management, powered by computer vision. His angel investments include more than 20 companies in the US and Europe. He holds a dual Masters from Columbia University and a Bachelors degree from Technical University Munich.
Follow Konstantin Mehl:
About Kaia Health, Kaia Health: Kaia Health is a digital therapeutics company that creates evidence-based treatments for a range of medical disorders.
Benjamin Cogan
Co-CEO and Co-founder of Hubble Contacts
Benjamin Cogan is a Co-CEO and Co-founder at Hubble Contacts. He is also the Co-Founder of Willow Underwear and Advisor at Mockingbird. Mr. Cogan is a former Senior Customer Insights Associate at Harry’s Grooming and Associate at The Boston Consulting Group. Benjamin received an AB in Philosophy at Princeton University.
Follow Benjamin Cogan:
About Hubble Contacts: Hubble is a contact lenses maker and retailer.
Jesse Horwitz
Co-CEO and Co-founder of Hubble Contacts
Jesse Horwitz is a Co-CEO and Co-Founder of Hubble Contacts. He is a former Investment Analyst at Columbia Investment Management Company and Founder of Gadfly Capital. Mr. Horwitz graduated from Columbia University in the City of New York with a bachelor of arts in Economics and Mathematics.
Follow Jesse Horwitz:
About Hubble Contacts: Hubble is a contact lenses maker and retailer.
Christopher Altchek
Founder & CEO of Cadence Solutions
Chris Altchek is CEO and co-founder of Mic, a leading news and media company for young people. Each month, more than 20 million readers rely on Mic’s unique sensibility to stay informed and make sense of the world. From global affairs and politics to technology and science to sports and music, Mic offers insightful stories and compelling perspectives on the issues that define a generation. Before starting Mic, Altchek worked in investment banking at Goldman Sachs. Earlier experiences include policy work for the National Economic Council at the White House, political organizing for the Service Employees International Union, and voter outreach for New York City Mayor Michael Bloomberg’s successful 2009 re-election. Altchek was named to the 2014 Forbes’s 30 Under 30 list.
Follow Christopher Altchek:
About Cadence Solutions, Lightspeed Venture Partners: Cadence Solutions is a provider of remote patient monitoring and virtual care services.
Adam Fine
Co-Founder, General Partner & CEO of Windham Venture Partners
Adam Fine is a co-founder and CEO of Windham Venture Partners. Adam is currently Director at GlySens, CuraSeal and HelpAround, Board Observer to SpineView, MC10, Holaira and VytronUS. Adam is a mentor in Blueprint Health, a healthcare IT accelerator in NYC. Prior to Windham, Adam was VP & GM at I-many, Inc., an enterprise software company. Prior to joining I-many, Adam was a New Business Development Analyst at Cordis Corporation, a Johnson & Johnson company focused on interventional vascular devices such as stents. In that capacity, Adam worked on a range of licenses, acquisitions, divestments, as well as strategic investments with Johnson & Johnson Development Corporation (JJDC), J&J’s strategic venture arm. Prior to J&J, Adam was a research analyst at Coopers & Lybrand’s Integrated Healthcare Consulting practice.
Follow Adam Fine:
About Windham Venture Partners: Founded in 2006, Windham is a New York City based venture capital firm focused on healthcare, with a particular emphasis on medical
Dieter Weinand
President and CEO of Bayer Pharmaceuticals
Weinand currently serves as President of Bayer Pharmaceuticals and is a member of the Board of Management of Bayer AG. Previously, he was President, Global Commercialization & Portfolio Management at Otsuka. During his 30 year career, he has held various responsibilities in commercial, operations and strategy in various therapeutic areas including cardiovascular diseases, oncology, dermatology, immunology, and respiratory and inflammatory diseases . These positions included heading business operations in markets in the United States, Asia-Pacific, Europe, the Middle East, Africa, and Latin America for companies including Pfizer and Bristol-Myers Squibb. He earned an M.S. in pharmacology and toxicology from Long Island University, New York, and a B.A. in biology from Concordia College, New York.
Follow Dieter Weinand:
About Bayer Pharmaceuticals: Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture.
Crystal Etienne
CEO and Founder of Ruby Love
Crystal Etienne is the CEO and founder of Ruby Love.
Follow Crystal Etienne:
About Ruby Love: Ruby Love is proprietary hygiene wearables with properly angled & built-in technology for incontinence and feminine care.
Alexander Kates
Cofounder & CEO of Vetcove
Cofounder and CEO of Vetcove.
Follow Alexander Kates:
About Vetcove: Vetcove is the largest B2B veterinary marketplace, enabling veterinary hospitals to compare and buy supplies from all of their vendors.
Ankur Jain
Founder & CEO of Kairos
Ankur Jain is the Founder & CEO of Kairos.
Follow Ankur Jain:
About Bilt Rewards, Kairos, Rhino: Kairos is a portfolio of brands that focuses on making life simpler and more affordable for our generation.
JT Kostman, PhD
Chief Executive Officer of ProtectedBy.AI
Data Scientist | Mathematician | Psychologist Dr. Kostman has been recognized by his peers, the press, and professional associations as one of the world’s leading experts in Applied Artificial Intelligence and Cognitive Computing. A highly sought-after speaker, writer, and advisor, JT has earned a reputation for his ability to demystify frontier technologies, and for developing practical, actionable, cost-efficient data solutions. In the public sector, JT has hunted terrorists for U.S. Intelligence Agencies, tracked criminal networks for the FBI, advised on analytic strategies for the Department of Defense, and led social media analysis for the 2012 Obama Campaign. In his earlier life, he served as a Paramedic, Police Officer, Deep-Sea Rescue Diver, and as a team leader with the U.S. Army Special Forces. In the corporate sector, JT led the development of industry-changing solutions while serving as Chief Data Officer for Time Inc., Chief Data Scientist for Samsung, and as an advisor to organizations ranging from tech startups to the Fortune 500. In the financial sector, JT has guided substantial investments in frontier technologies while serving as a Board Member of a PE/VC fund and as an advisor to numerous hedge funds, family offices, and institutional investors. In the marketplace of ideas, JT has become one of the most prolific, prescient and valued voices on the near-term impact of AI and frontier technologies. The keynotes, presentations, press interviews, posts and articles he has shared with audiences around the world have contributed to making him a go-to expert for organizations including The National Association of Corporate Directors, The Chicago Council on Global Affairs, U.S. Government Agencies, and dozens of others.
Follow JT Kostman, PhD:
About ProtectedBy.AI: Artificial Intelligence Software
Dov Biran
CEO of Fitango Health
Follow Dov Biran:
About Fitango Health: Fitango Health is a cloud based population health management platform integrating patient engagement and care management
Zack Gray
Co-Founder & CEO of Ophelia
Zack Gray is the Founder and CEO at Ophelia .
Follow Zack Gray:
About Ophelia: Ophelia offers medication and support for quitting opioids.
John Buser
President and Chief Executive Officer of Health Solutions Plus
Health Solutions Plus was founded in 1996, by John Buser, founder and former COO and CIO of Centercare, a New York health plan. Before founding HSP, Mr. Buser spent 30 years in technology, software and operations management and served in senior leadership. Prior to joining the healthcare industry, Mr. Buser was the senior technical manager for international consulting firm Logica LLC. During his tenure at Logica, Mr. Buser was responsible for developing banking and telecommunications systems for such clients as Citibank, Chase, JP Morgan, Chemical, MHT, Philadelphia Federal Reserve Bank, Bank of Boston and IBM.
Follow John Buser:
About Health Solutions Plus: Health Solutions Plus (HSP) is a U.S. based software provider of the most modern Payer administration solutions in the industry.
David Benshoof Klein
Founder & CEO of Click Therapeutics
David Benshoof Klein is a healthcare investor and entrepreneur with over 13 years life science industry experience; he has played key roles in founding, financing and developing more than 10 life science companies. In 2012, Mr. Klein co-founded Click Therapeutics, Inc. which focuses on engineering, validating and commercializing Digital Therapeutics™ applications to benefit people with brain disorders and neuropsychiatric dysfunction. He formerly served as Managing Director at a life science asset management firm & senior consultant to Pfizer.
Follow David Benshoof Klein:
About Click Therapeutics: Click Therapeutics delivers safe and effective digital treatments to patients in need.
Robert J. Hariri, M.D., Ph.D.
Founder, Chairperson, and Chief Executive Officer of Celularity
Robert J. Hariri joined us as a Director in July 2011 and was elected Chairman of the Board in April 2012. Robert Hariri has served as the chairman and chief scientific officer of Celgene Cellular Therapeutics, a division of Celgene Corporation (NASDAQ: CELG), since 2014. From 2002 to 2014, he served in various positions at Celgene Cellular Therapeutics, including chief executive officer and president. Prior to joining Celgene Cellular Therapeutics, Robert Hariri was founder, chairman and chief scientific officer at Anthrogenesis Corporation/LIFEBANK, Inc., a privately held biomedical technology and service corporation involved in the area of human stem cell therapeutics, which was acquired by Celgene Corporation in 2002. Robert Hariri also serves as president of Human Longevity Cellular Therapeutics, Inc., a privately-held genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, which he co-founded in 2013. He has also served as co-founder, vice chairman and chief scientific officer of Neurodynamics, a privately held medical device and technology corporation. Robert Hariri is an adjunct associate professor of pathology at the Mount Sinai School of Medicine and has also held key academic positions at Weill Medical College of Cornell University and the Cornell University Graduate School of Medical Science, including serving as the director of the Center for Trauma Research. Robert Hariri is also a director of Cryoport, Inc. (NASDAQ: CYRX), Bionik Laboratories Corp. (OTCQX: BNKL), Provista Diagnostics and Rocket Racing, Inc. Robert Hariri is a member of the scientific advisory board for the Archon X Prize for Genomics, which is awarded by the X Prize Foundation. Robert Hariri also serves as a trustee of the J. Craig Venter Institute, a trustee of the Liberty Science Center and a commissioner of the New Jersey Commission for Cancer Research. Robert Hariri received the Thomas Alva Edison Award in 2007 and 2011, The Fred J. Epstein Lifetime Achievement Award in 2012 and numerous other honors for his contributions to biomedicine and aviation. He has served as a member of the board of visitors at Columbia University School of Engineering & Applied Sciences and the Science & Technology Council of the College of Physicians and Surgeons. Robert Hariri received his undergraduate training at Columbia College and Columbia University School of Engineering and Applied Sciences and was awarded his M.D. and Ph.D. degrees from Cornell University Medical College. Robert Hariri received his surgical training at The New York Hospital-Cornell Medical Center and directed the Aitken Neurosurgery Laboratory and the Center for Trauma Research. We believe Robert Hariri’s training as a scientist, his knowledge and experience with respect to the biomedical and pharmaceutical industries and his extensive research and experience qualifies him to serve on our Board of Directors.
Follow Robert J. Hariri, M.D., Ph.D.:
About Celularity, Human Longevity, Icahn School of Medicine at Mount Sinai, MYOS: Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.
Simon Bolz
Co-founder, Co-CEO of Klara
Simon was first employee at onefootball, then founded his own agency spezializing in Digital Communication and Product Development for the Health Care Industry. Simon’s agency worked to optimize the patient experience and improve customer satisfaction across medical practices, clinics and healthcare companies. The increasingly important role of the internet in doctor-patient communication prompted him to found goderma in 2013 together with Simon Lorenz, an expert from the world of healthcare economics. Simon is Co-Founder and Managing Director of Klara (goderma Inc.) where he is responsible for Product and Marketing. Simon began his graduate studies at the London School of Economics as well as the Humbold Universität zu Berlin and later went on to receive a Masters in Political Science from the New School in New York, NY.
Follow Simon Bolz:
About Klara: Klara is an end-to-end virtual care platform that helps healthcare providers stay connected with their patients.
Simon Lorenz
Co-Founder & Co-CEO of Klara
Follow Simon Lorenz:
About Klara: Klara is an end-to-end virtual care platform that helps healthcare providers stay connected with their patients.
Alexander Bisignano
Co-Founder & Chief Executive Officer of Phosphorus
Alexander Bisignano is the Co-Founder & Chief Executive Officer at Phosphorus.
Follow Alexander Bisignano:
About Phosphorus: Phosphorus provides the back-end infrastructure that enables ubiquitous integration of genetics in medicine.
Thomas Lee
CEO of Galileo
Tom is a board-certified internist who completed training at Harvard’s Brigham and Women’s Hospital. He’s interested in improving the quality of care through team-based decision making and an integrative philosophy of care that includes evidence-based medicine and biologic plausibility.
Follow Thomas Lee:
About Galileo: Galileo — a next-generation health care delivery model designed for the future.
